Urban Supreme System

Suddenly appearing in the place where Su Zhe and Xiao Hui were running, it was the general killer Dog Shadow.

Yesterday, the old housekeeper of Zheng Yan's villa obeyed Zheng Yan's instructions and issued an assassination mission to the killer organization to which Quan Ying belonged. The reward was 3 million, and he also designated the assassin as Quan Ying.

As long as the remuneration exceeds one million, the client can of course appoint a satisfactory killer. Of course, if the killer is not familiar with it, the killer organization can also recommend a killer.

The killer organization accepted the information provided by the old butler, combined it with the intelligence they obtained, and took over the assassination mission with a reward of 3 million, and then handed the task to the dog shadow designated by the old butler.

After receiving the mission from the killer organization, Quanying started the official operation today. Although the information provided by Zheng Yan contained detailed information and habits of the assassination target, Quanying still came to visit the situation first to see the relationship between the assassination target and Does Zheng Yan's information match it?

And now Quan Ying appears behind Su Zhe and monitors Su Zhe's every move. This has already explained a lot of things. It is obvious that the target of the assassination mission given to Quan Ying by Zheng Yan this time is Su Zhe, otherwise Quanying will not come here to test Su Zhe's situation.

But thinking about it, this is also a normal thing, because Su Zhe and Zheng Yan have had troubles several times before, and they have deep grudges with each other. It is also very normal for Zheng Yan, who is determined to retaliate, to want to kill Su Zhe. Su Zhe has also been guarding against Zheng Yan. .

Zheng Yan could endure it until now before letting Quan Ying take action, which surprised Su Zhe, but Su Zhe did not take it lightly.

There was a reason why Zheng Yan didn't forget to deal with Su Zhe at such a juncture.

Because Zheng Yan has investigated clearly and found out that the largest shareholder of Changhua Pharmaceutical, which has been making a splash in the pharmaceutical market recently, is Su Zhe, who owns 85% of the shares of Changhua Pharmaceutical. Liu Xiong and Li Changhua, who are also shareholders, own only 15% of the shares of Changhua Pharmaceutical. Far inferior to Su Zhe.

At first, when Changhua Pharmaceutical first launched Mepilin and Xingshen tablets, it attracted the attention of Zheng Pharmaceutical Group. They immediately began researching and deciphering the ingredients of the drug, and analyzed the market value of Mepilin and Xingshen tablets.

Of course, in the end, it was naturally impossible for Zheng's Pharmaceutical Group to decipher the ingredients of Mepilin and Xingshen tablets. Not only did Zheng's Pharmaceutical Group decipher the ingredients, but so did other pharmaceutical companies.

According to the analysis of Zheng's Pharmaceutical Group, they all believe that judging from the effects of these two drugs, the market value contained in them is very large.

So Zheng's Pharmaceutical Group has considered acquiring Changhua Pharmaceutical.

At that time, before the advent of Mianbi Ling and Xingshen tablets, Changhua Pharmaceutical was only worth about 160 million. The wealthy Zheng Pharmaceutical Group directly offered 500 million to acquire Changhua Pharmaceutical.

At first, Zheng's Pharmaceutical Group thought that Changhua Pharmaceutical would definitely accept this price enthusiastically. After all, the purchase price was quite high. At that time, there were many pharmaceutical groups that wanted to acquire Changhua Pharmaceutical, but none of them reported. The purchase price offered was higher than that of Zheng Pharmaceutical Group.

The reason why Zheng's Pharmaceutical Group offered such a high price was, firstly, because they were optimistic about the market value of Mepilin and Xingshen tablets, and secondly, because Zheng's Pharmaceutical Group had not long been established and their foundation was not yet stable.

After all, the Zheng family's focus in the early years was on the jewelry industry. Only in recent years has the Zheng family begun to shift its focus from the jewelry industry to the pharmaceutical industry. Although the Zheng Pharmaceutical Group, which has deep pockets, spent a total of US$18 billion to acquire a pharmaceutical company, including formulas worth US$8 billion.

But compared to other pharmaceutical companies that have been developing for a long time. Zheng's Pharmaceutical Group is still slightly lacking, so Zheng's Pharmaceutical Group needs Mepilin and Xingshen tablets to support the situation.

The final result at that time was that Changhua Pharmaceutical rejected all acquisitions by pharmaceutical groups, including Zheng Pharmaceutical Group, which offered a purchase price of 500 million.

Therefore, the acquisition plan failed. Although Zheng Yan was involved in the acquisition plan at the time, Zheng Yan himself did not attach importance to Mianbi Ling and Xingshen tablets, so even if the plan failed, Zheng Yan thought it was no big deal.

But soon afterwards, Changhua Pharmaceutical caused an uproar in the pharmaceutical market, and even the international pharmaceutical market was shocked. Because Changhua Pharmaceutical has launched Thiefoling, which can treat ALS.

The huge value contained in this Thawing Spirit can be seen by any pharmaceutical group. Of course, Zheng's Pharmaceutical Group was also very excited.

Pharmaceutical companies with almost any strength immediately began to decipher the ingredients of Thawling. Because Changhua Pharmaceutical has not applied for patent protection for Thieling Ling, which means that as long as the ingredients can be cracked, it can be directly produced to share this tempting cake.

But what makes all pharmaceutical companies hate it is that even if Changhua Pharmaceutical has not applied for patent protection, other pharmaceutical companies do not understand the production of Dongling, because others cannot crack it at all, no matter how much resources are invested. Nope either.

After the cracking failed, the only option was acquisition, and Zheng Pharmaceutical Group did the same.

Zheng Pharmaceutical Group once again approached Changhua Pharmaceutical. This time it still offered 500 million yuan, but it was already converted into US dollars, which was 3.1 billion yuan.

But this time Changhua Pharmaceutical still refused without hesitation, and did not give Zheng Pharmaceutical Group another chance to raise a price. Changhua Pharmaceutical directly made it clear to everyone that Changhua Pharmaceutical would pay no matter how much money it cost. It will not be sold, and the same is true for the formula.

This time, Zheng Yan could no longer be as indifferent as before. He knew that Zheng's Pharmaceutical Group valued Thiefoling very much.

So Zheng Yan started asking people to investigate the information of Changhua Pharmaceutical. Only then did Zheng Yan discover that the largest shareholder of Changhua Pharmaceutical was Su Zhe, which made him very angry.

And Zheng Yan also knew very well that as long as Su Zhe still existed, Zheng Pharmaceutical Group would never be able to acquire Changhua Pharmaceutical.

In fact, Zheng Yan was right. Even if Su Zhe wanted to sell Changhua Pharmaceutical, Su Zhe would not sell it to Zheng Pharmaceutical Group. The most likely thing would be competition to sell Changhua Pharmaceutical to Zheng Pharmaceutical Group. Opponent, of course Su Zhe cannot transfer Changhua Pharmaceutical.

And Su Zhe is not worried that Liu Xiong and Li Changhua's shares will be acquired by others, because they have already discussed it at that time, and it is also specifically stated in the contract. If Liu Xiong and Li Changhua want to sell their shares, Su Zhe has priority. Right to purchase. (To be continued) ()